Literature DB >> 21135845

Crippling SWI-SNF makes tumors GLI-ful.

Jeremy F Reiter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21135845     DOI: 10.1038/nm1210-1374

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

1.  Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice.

Authors:  C W Roberts; S A Galusha; M E McMenamin; C D Fletcher; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.

Authors:  Zainab Jagani; E Lorena Mora-Blanco; Courtney G Sansam; Elizabeth S McKenna; Boris Wilson; Dongshu Chen; Justin Klekota; Pablo Tamayo; Phuong T L Nguyen; Michael Tolstorukov; Peter J Park; Yoon-Jae Cho; Kathy Hsiao; Silvia Buonamici; Scott L Pomeroy; Jill P Mesirov; Heinz Ruffner; Tewis Bouwmeester; Sarah J Luchansky; Joshua Murtie; Joseph F Kelleher; Markus Warmuth; William R Sellers; Charles W M Roberts; Marion Dorsch
Journal:  Nat Med       Date:  2010-11-14       Impact factor: 53.440

3.  Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours.

Authors:  N Dahmane; J Lee; P Robins; P Heller; A Ruiz i Altaba
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

4.  Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.

Authors:  Zhi-Kai Zhang; Kelvin P Davies; Jeffrey Allen; Liang Zhu; Richard G Pestell; David Zagzag; Ganjam V Kalpana
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

5.  c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.

Authors:  S W Cheng; K P Davies; E Yung; R J Beltran; J Yu; G V Kalpana
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

6.  brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2.

Authors:  J W Tamkun; R Deuring; M P Scott; M Kissinger; A M Pattatucci; T C Kaufman; J A Kennison
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

7.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

8.  Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1.

Authors:  M Nilsson; A B Undèn; D Krause; U Malmqwist; K Raza; P G Zaphiropoulos; R Toftgård
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

9.  Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation.

Authors:  H L Park; C Bai; K A Platt; M P Matise; A Beeghly; C C Hui; M Nakashima; A L Joyner
Journal:  Development       Date:  2000-04       Impact factor: 6.868

10.  p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci.

Authors:  Cristiano Simone; Sonia Vanina Forcales; David A Hill; Anthony N Imbalzano; Lucia Latella; Pier Lorenzo Puri
Journal:  Nat Genet       Date:  2004-06-20       Impact factor: 38.330

View more
  1 in total

1.  Concurrent Control of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: a New Prospect for the Therapeutic Potential of Lipoxin A4.

Authors:  Kumari Asha; Natalie Balfe; Neelam Sharma-Walia
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.